Commissioner of Food and Drugs
Executive orders directing the Commissioner of Food and Drugs · 5 in Trump 45 · 15 all terms.
Related departments
Orders
5 shown · Trump 45
An America-First Healthcare Plan
This executive order declares a continuation of healthcare policies emphasizing patient choice, lower costs, and quality care, with specific directives to maintain existing actions and new deadlines for price transparency and surprise billing measures. It requires HHS to work with Congress on surprise billing legislation by year-end 2020, take administrative action if legislation fails, and update Medicare.gov Hospital Compare within 180 days with hospital billing quality information.
Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States
This executive order directs federal agencies to prioritize domestic procurement of essential medicines, medical countermeasures, and their critical ingredients to reduce dependence on foreign manufacturing. It mandates supply chain vulnerability assessments, streamlines regulatory approvals for domestic producers, and authorizes use of the Defense Production Act to prioritize these materials. The order includes exceptions for public health emergencies and when domestic procurement would increase costs by more than 25 percent.
Promoting American Seafood Competitiveness and Economic Growth
This executive order directs federal agencies to reduce regulatory barriers for domestic fishing and aquaculture, combat illegal fishing, streamline permitting for offshore aquaculture projects, establish designated aquaculture zones, and develop a comprehensive seafood trade strategy. It creates multiple task forces and deadlines across Commerce, Agriculture, Army Corps of Engineers, and other agencies to expand U.S. seafood production and reduce reliance on imports.
Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health
This executive order establishes a National Influenza Vaccine Task Force co-chaired by Defense and HHS to modernize U.S. influenza vaccine production away from egg-based methods toward faster, scalable cell-based and recombinant technologies. It mandates a 5-year national plan and directs multiple agencies to estimate costs, expand manufacturing capacity, and accelerate development of broadly protective vaccines.
Modernizing the Regulatory Framework for Agricultural Biotechnology Products
This executive order directs federal agencies to modernize regulations for agricultural biotechnology products, streamline oversight across USDA, EPA, and FDA, and promote both domestic public acceptance and international trade of genetically engineered crops and animals. It mandates specific plans for regulatory streamlining, a unified web-based platform for developers, consumer engagement strategies, and international trade barrier removal.